Ngā hua rapu - Erin R. Rudzinski
- E whakaatu ana i te 1 - 20 hua o te 30
- Haere ki te Whārangi Whai Ake
-
1
Thyroid Cancer in the Pediatric Population mā Vera Paulson, Erin R. Rudzinski, Douglas S. Hawkins
I whakaputaina 2019Revisão -
2
What is new in the biology and treatment of pediatric rhabdomyosarcoma? mā Douglas S. Hawkins, Abha A. Gupta, Erin R. Rudzinski
I whakaputaina 2013Revisão -
3
-
4
-
5
-
6
-
7
The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group mā Erin R. Rudzinski, James R. Anderson, Douglas S. Hawkins, Stephen X. Skapek, David M. Parham, Lisa A. Teot
I whakaputaina 2015Artigo -
8
-
9
Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription Factors mā Kyle L. MacQuarrie, Zizhen Yao, Abraham Fong, Scott J. Diede, Erin R. Rudzinski, Douglas S. Hawkins, Stephen J. Tapscott
I whakaputaina 2012Artigo -
10
<i>PAX-FOXO1</i>fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report mā Stephen X. Skapek, James R. Anderson, Frederic G. Barr, Julia A. Bridge, Julie M. Gastier‐Foster, David M. Parham, Erin R. Rudzinski, Timothy J. Triche, Douglas S. Hawkins
I whakaputaina 2013Artigo -
11
Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials mā Sapna Oberoi, Wei Xue, Amira Qumseya, Thomas J. Scharschmidt, Odion Binitie, Joel Sorger, Kiran A Kumar, Kenneth Wong, Sarah S. Donaldson, Lisa A. Teot, Erin R. Rudzinski, Rajkumar Venkatramani
I whakaputaina 2025Artigo -
12
Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma mā Erin R. Rudzinski, Lisa A. Teot, James R. Anderson, Julie Moore, Julia A. Bridge, Frederic G. Barr, Julie M. Gastier‐Foster, Stephen X. Skapek, Douglas S. Hawkins, David M. Parham
I whakaputaina 2013Artigo -
13
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low‐Risk Clinical Features: A Report From the Children's Oncology Group mā Michael Arnold, James R. Anderson, Julie M. Gastier‐Foster, Frederic G. Barr, Stephen X. Skapek, Douglas S. Hawkins, R. Beverly Raney, David M. Parham, Lisa A. Teot, Erin R. Rudzinski, David Walterhouse
I whakaputaina 2016Artigo -
14
Myogenin, AP2β, NOS-1, and HMGA2 Are Surrogate Markers of Fusion Status in Rhabdomyosarcoma mā Erin R. Rudzinski, James R. Anderson, Elizabeth Lyden, Julia A. Bridge, Frederic G. Barr, Julie M. Gastier‐Foster, Karen M. Bachmeyer, Stephen X. Skapek, Douglas S. Hawkins, Lisa A. Teot, David M. Parham
I whakaputaina 2014Artigo -
15
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Onco... mā Emily Hibbitts, Yueh‐Yun Chi, Douglas S. Hawkins, Frederic G. Barr, Julie A. Bradley, Roshni Dasgupta, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Sheri L. Spunt, Stephen X. Skapek, Suzanne L. Wolden, Carola A.S. Arndt
I whakaputaina 2019Artigo -
16
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from... mā Abha A. Gupta, Wei Xue, Douglas J Harrison, Douglas S. Hawkins, Roshni Dasgupta, Suzanne Wolden, Barry Shulkin, Amira Qumseya, Jonathan C Routh, Tamara MacDonald, Shari L. Feinberg, Brian Crompton, Erin R. Rudzinski, Michael Arnold, Raj Venkatramani
I whakaputaina 2024Artigo -
17
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma mā Alyssa J. Penning, Alyaa Al‐Ibraheemi, Michael Michal, Brandon T. Larsen, Soo‐Jin Cho, Christina M. Lockwood, Vera Paulson, Yajuan J. Liu, Lukáš Plank, Karen Fritchie, Carol Beadling, Tanaya Neff, Christopher L. Corless, Erin R. Rudzinski, Jessica L. Davis
I whakaputaina 2021Artigo -
18
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group mā Erin R. Rudzinski, James R. Anderson, Yueh‐Yun Chi, Julie M. Gastier‐Foster, Caroline Astbury, Frederic G. Barr, Stephen X. Skapek, Douglas S. Hawkins, Brenda J. Weigel, Alberto S. Pappo, William H. Meyer, Michael Arnold, Lisa A. Teot, David M. Parham
I whakaputaina 2017Artigo -
19
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib mā James Chih‐Hsin Yang, Marcia S. Brose, Gilberto de Castro, Edward S. Kim, Ulrik Lassen, Serge Leyvraz, Alberto S. Pappo, Fernando López‐Ríos, John A. Reeves, Marc Fellous, Frédérique Penault‐Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan C. Trent
I whakaputaina 2022Artigo -
20
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group mā Jacquelyn Crane, Wei Xue, Amira Qumseya, Zhengya Gao, Carola A.S. Arndt, Sarah S. Donaldson, Douglas J. Harrison, Douglas S. Hawkins, Corinne M. Linardic, Leo Mascarenhas, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Barry L. Shulkin, David Walterhouse, Rajkumar Venkatramani, Aaron R. Weiss
I whakaputaina 2022Revisão
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Pathology
Internal medicine
Sarcoma
Oncology
Rhabdomyosarcoma
Biology
Cancer
Gene
Genetics
Cancer research
Receptor
Neurotrophin
Trk receptor
Clinical trial
Fusion gene
Surgery
Biochemistry
Embryonal rhabdomyosarcoma
Environmental health
Immunohistochemistry
Pediatrics
Population
Alveolar rhabdomyosarcoma
Artificial intelligence
Bioinformatics
Chemotherapy
Clinical endpoint
Cog
Computer science